AbbVie | ABBV - Debt

Stock Price
218.12
Daily Change
-7.54 -3.34%
Monthly
-0.94%
Yearly
13.75%
Q1 Forecast
216.14

AbbVie reported $1000K in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
AbbVie USD 1000K 70.48B Sep/2025
Abbott USD 12.94B 496M Sep/2025
ALKERMES USD 72.68M 293.32M Jun/2025
Amgen USD 54.59B 1.62B Sep/2025
AstraZeneca USD 32.84B 1.19B Jun/2025
Biogen USD 6.29B 309.5M Sep/2025
BioMarin Pharmaceutical USD 603.87M 8.22M Jun/2025
Bristol-Myers Squibb USD 50.93B 1.22B Jun/2025
Eisai JPY 187.52B 31.58B Mar/2025
Eli Lilly USD 42.51B 2.6B Sep/2025
Gilead Sciences USD 24.95B 6M Jun/2025
GlaxoSmithKline GBP 17.75B 396M Sep/2025
J&J USD 45.8B 4.97B Sep/2025
Medtronic USD 28.61B 93M Jun/2025
Merck USD 41.37B 5.97B Sep/2025
Neurocrine Biosciences USD 439.1M 8.4M Jun/2025
Novartis USD 32.64B 1.37B Jun/2025
Pacira USD 376.72M 203.77M Sep/2025
Perrigo USD 3.65B 454.7M Jun/2025
Pfizer USD 60.85B 78M Sep/2025
Regeneron Pharmaceuticals USD 2.71B 400K Sep/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
Sanofi EUR 21.76B 530M Sep/2025
UCB EUR 3.03B 12M Dec/2024
Ultragenyx Pharmaceutical USD 36.3M 1.98M Jun/2025
United Therapeutics USD 200M 100M Mar/2025
Vertex Pharmaceuticals USD 1.53B 121.7M Jun/2025
Zoetis USD 6.79B 1.11B Jun/2025